Urinary proteome profiling for stratifying patients with familial Parkinson's disease
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
Urinary proteome profiling for stratifying patients with familial Parkinson's disease
SV Winter, O Karayel, MT Strauss, S Padmanabhan… - bioRxiv, 2020 - biorxiv.org
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
[PDF][PDF] Urinary proteome profiling for stratifying patients with familial Parkinson's disease
SV Winter, O Karayel, MT Strauss, S Padmanabhan… - scholar.archive.org
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
[HTML][HTML] Urinary proteome profiling for stratifying patients with familial Parkinson's disease
SV Winter, O Karayel, MT Strauss… - EMBO Molecular …, 2021 - ncbi.nlm.nih.gov
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
[PDF][PDF] Urinary proteome profiling for stratifying patients with familial Parkinson's disease
S Virreira Winter, O Karayel, MT Strauss… - EMBO Molecular …, 2021 - embopress.org
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
Urinary proteome profiling for stratifying patients with familial Parkinson's disease.
O Karayel, MT Strauss, S Padmanabhan… - EMBO Molecular …, 2021 - europepmc.org
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
Urinary proteome profiling for stratifying patients with familial Parkinson's disease
SV Winter, O Karayel, MT Strauss… - EMBO molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
Urinary proteome profiling for stratifying patients with familial Parkinson's disease
S Virreira-Winter, O Karayel, MT Strauss… - Embo Molecular …, 2021 - pure.mpg.de
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
Urinary proteome profiling for stratifying patients with familial Parkinson's disease
SV Winter, O Karayel, MT Strauss… - EMBO Molecular …, 2021 - search.proquest.com
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …
[HTML][HTML] Urinary proteome profiling for stratifying patients with familial Parkinson's disease
SV Winter, O Karayel, MT Strauss… - EMBO Molecular …, 2021 - embopress.org
The prevalence of Parkinson's disease (PD) is increasing but the development of novel
treatment strategies and therapeutics altering the course of the disease would benefit from …
treatment strategies and therapeutics altering the course of the disease would benefit from …